Physician profile
Nouman Mujahid
NPI 1467982736
$183,835.96
in general payments reported to CMS, 2019-2025
9 companies · $177K in 2025
The $177K reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,573 · 2020: $340 · 2021: $934 · 2022: $2,810 · 2023: $1,500 · 2024: $162 · 2025: $177K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $176K · Honoraria: $1,500 · Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $176,459.85 |
| Honoraria | $1,500.00 |
| Food and Beverage | $219.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $176,459.85 | 2025 | |
| Dentsply Sirona INC | $2,739.58 | 2019-2022 | |
| Ivoclar Vivadent, INC. | $2,664.87 | 2020-2022 | |
| Sprintray INC | $1,500.00 | 2023 | |
| Align Technology, INC. | $179.74 | 2024-2025 | Invisalign |
| Benco Dental Supply Co. | $134.64 | 2019 | |
| Neoss, INC. | $92.87 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $39.80 | 2024 | Arestin, Ossix Plus |
| Zimmer Biomet Holdings, INC. | $24.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nouman Mujahid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.